News
SGRY
24.84
-2.59%
-0.66
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion
Surgery Partners, Inc.'s (NASDAQ:SGRY) price-to-sales ratio is 1.2x. The median P/S for the Healthcare industry in the United States is very similar to the company's growth rate. The company's revenue growth has been sluggish in recent years. But the company has grown revenues 47% in the last year and is expected to do so again.
Simply Wall St · 2d ago
Baron Health Care Fund Q1 2024 Shareholder Letter
Baron Health Care Fund advanced 8.92% in the quarter ended March 31, 2024. The Fund's performance was in line with the Russell 3000 Health Care Index and the S&P 500 Index. Investments in health care equipment, pharmaceuticals, and life sciences added the most value in the period.
Seeking Alpha · 3d ago
Weekly Report: what happened at SGRY last week (0415-0419)?
Weekly Report · 4d ago
Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details
Surgery Partners, Inc. Will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024. The Company is a leading short-stay surgical facility owner and operator. The company will hold a conference call to follow the release of the results.
Barchart · 04/18 00:06
ClearBridge Select Strategy Q1 2024 Portfolio Manager Commentary
Seeking Alpha · 04/17 09:20
Weekly Report: what happened at SGRY last week (0408-0412)?
Weekly Report · 04/15 09:08
SURGERY PARTNERS INC <SGRY.O>: MIZUHO CUTS TARGET PRICE TO $35 FROM $42
Reuters · 04/11 11:45
Surgery Partners Inc Refinances Debt and Secures New Funding
TipRanks · 04/10 21:02
Surgery Partners Price Target Maintained With a $43.00/Share by Cantor Fitzgerald
Dow Jones · 04/10 14:38
Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $43 Price Target
Benzinga · 04/10 14:28
Weekly Report: what happened at SGRY last week (0401-0405)?
Weekly Report · 04/08 09:09
Surgery Partners Inc: Statement of changes in beneficial ownership of securities
Press release · 04/05 21:06
While shareholders of Surgery Partners (NASDAQ:SGRY) are in the black over 5 years, those who bought a week ago aren't so fortunate
Surgery Partners, Inc. Shareholders have received 131% returns over the last five years. The share price has dropped 13% in the last quarter, but shareholders are down 23% for the year. In the last 5 years Surgery Partners saw its revenue grow at a rate of 10% per year. It's worth looking at the growth trend of the business over the long term.
Simply Wall St · 04/05 10:12
Weekly Report: what happened at SGRY last week (0325-0329)?
Weekly Report · 04/01 09:09
Surgery Partners: A Buy Rating Amidst Underperformance and Growth Potential
TipRanks · 03/29 07:07
Surgery Partners Subsidiary Announces $600M Notes Offering
TipRanks · 03/26 12:44
Surgery Partners to offer $600M senior unsecured notes
Healthcare Surgery Partners to offer $600M senior unsecured notes due 2032. Surgery Partners (NASDAQ:SGRY) said on Monday that the surgical facility operator intends to offer the notes. The notes will be guaranteed by each domestic wholly-owned subsidiary of the company.
Seeking Alpha · 03/26 12:39
Weekly Report: what happened at SGRY last week (0318-0322)?
Weekly Report · 03/25 09:09
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Surgery Partners has a return on capital employed of 6.5%. The company has grown its capital employed 47% in the last five years. It has a low rate of returns on capital, compared to the Healthcare industry average of 11%. Surgery Partners has earned a 140% return in the past 5 years. The company is not a good investment for those looking to buy a stock.
Simply Wall St · 03/18 10:21
Weekly Report: what happened at SGRY last week (0311-0315)?
Weekly Report · 03/18 09:09
More
Webull provides a variety of real-time SGRY stock news. You can receive the latest news about Surgery Partners Inc through multiple platforms. This information may help you make smarter investment decisions.
About SGRY
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Its segments include Surgical Facility Services and Ancillary Services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology and general surgery. The Ancillary Services segment consisted of multi-specialty physician practices, including physician practices owned and operated pursuant to long-term management service agreements. It is focused on surgical services businesses in the United States, with over 180 locations in 33 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices.